AI assistant
Sending…
Structure Therapeutics Inc. — Director's Dealing 2023
Feb 6, 2023
31940_dirs_2023-02-06_b9aff4bf-ebcf-4ca4-9f1c-057c432facb1.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: Structure Therapeutics Inc. (GPCR)
CIK: 0001888886
Period of Report: 2023-02-02
Reporting Person: Stevens Raymond C (Director, Chief Executive Officer)
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2023-02-02 | Stock option (right to buy) | $15.00 | A | 1600000 | Acquired | 2033-02-01 | Ordinary Shares (1600000) | Direct |
Footnotes
F1: 1/4th of the shares subject to the option shall vest on the first anniversary of February 2, 2023, and the remaining shares shall vest in 36 equal monthly installments thereafter.
More from Structure Therapeutics Inc.
Regulatory Filings
2026
May 7
Annual Report
2026
Apr 23
Regulatory Filings
2026
Apr 15
Annual Report
2026
Feb 26
Regulatory Filings
2026
Feb 26
Major Shareholding Notification
2026
Feb 17
Major Shareholding Notification
2026
Feb 13
Major Shareholding Notification
2026
Feb 10
Major Shareholding Notification
2026
Feb 5
Director's Dealing
2026
Jan 20